{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:47Z","timestamp":1793296067294,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ard.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:17:42Z","timestamp":1784546262000},"page":"1899-1903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Varicella-zoster virus reactivation and cardiovascular risk: implications for patients receiving JAK inhibitors"],"prefix":"10.1016","volume":"85","author":[{"given":"Fabio","family":"Cacciapaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-6736","authenticated-orcid":false,"given":"Massimo","family":"Gadina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.06.027_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"10.1016\/j.ard.2026.06.027_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11908-014-0407-z","article-title":"Update on varicella zoster virus vasculopathy","volume":"16","author":"Nagel","year":"2014","journal-title":"Curr Infect Dis Rep."},{"issue":"10","key":"10.1016\/j.ard.2026.06.027_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat Rev Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.06.027_bib0004","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ard.2026.06.027_bib0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/WNL.0b013e3182267bfa","article-title":"Varicella zoster virus vasculopathy: analysis of virus-infected arteries","volume":"77","author":"Nagel","year":"2011","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.ard.2026.06.027_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.001","article-title":"Ischemic stroke due to virologically confirmed varicella zoster virus vasculopathy: a case series","volume":"28","author":"Hoshino","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"23","key":"10.1016\/j.ard.2026.06.027_bib0007","doi-asserted-by":"crossref","first-page":"10527","DOI":"10.1128\/JVI.01546-16","article-title":"Varicella-zoster virus downregulates programmed death ligand 1 and major histocompatibility complex class I in human cells","volume":"90","author":"Jones","year":"2016","journal-title":"J Virol."},{"issue":"5","key":"10.1016\/j.ard.2026.06.027_bib0008","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000382","article-title":"Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment","volume":"4","author":"Jones","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"5","key":"10.1016\/j.ard.2026.06.027_bib0009","first-page":"e474","article-title":"Microparticle-mediated VZV propagation and endothelial activation: mechanism of VZV vasculopathy","volume":"9","author":"Eleftheriou","year":"2020","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.ard.2026.06.027_bib0010","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.019","article-title":"High-resolution vessel wall MRI in varicella-zoster virus vasculitis","volume":"25","author":"Tsivgoulis","year":"2016","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"8","key":"10.1016\/j.ard.2026.06.027_bib0011","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/jiac405","article-title":"Zoster-associated prothrombotic plasma exosomes and increased stroke risk","volume":"227","author":"Bubak","year":"2023","journal-title":"J Infect Dis."},{"issue":"4","key":"10.1016\/j.ard.2026.06.027_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2556","article-title":"Epidemiologic evidence on herpes zoster and stroke risk: a systematic review and meta-analysis","volume":"34","author":"Heiat","year":"2024","journal-title":"Rev Med Virol."},{"issue":"12","key":"10.1016\/j.ard.2026.06.027_bib0013","article-title":"Herpes zoster and the risk of myocardial infarction and stroke","volume":"12","author":"Minassian","year":"2015","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.ard.2026.06.027_bib0014","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/cid\/ciu098","article-title":"Risk of stroke following herpes zoster: a self-controlled case series","volume":"58","author":"Langan","year":"2014","journal-title":"Clin Infect Dis."},{"issue":"11","key":"10.1016\/j.ard.2026.06.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166554","article-title":"Risk of stroke after herpes zoster: a self-controlled case series study","volume":"11","author":"Schink","year":"2016","journal-title":"PLOS One."},{"issue":"10","key":"10.1016\/j.ard.2026.06.027_bib0016","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3181d31e5c","article-title":"Herpes zoster ophthalmicus and risk of stroke: a population-based study","volume":"74","author":"Lin","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.ard.2026.06.027_bib0017","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12879-015-1170-y","article-title":"Incidence of herpes zoster and associated events including stroke","volume":"15","author":"Sundstr\u00f6m","year":"2015","journal-title":"BMC Infect Dis."},{"issue":"2","key":"10.1016\/j.ard.2026.06.027_bib0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/art.39855","article-title":"Herpes zoster and stroke risk in autoimmune diseases","volume":"69","author":"Calabrese","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.ard.2026.06.027_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006304","article-title":"Neurological complications of herpes zoster and stroke risk in rheumatoid arthritis","volume":"6","author":"Liao","year":"2017","journal-title":"J Am Heart Assoc."},{"issue":"7","key":"10.1016\/j.ard.2026.06.027_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181565","article-title":"Herpes zoster and risk of cardiovascular events: systematic review and meta-analysis","volume":"12","author":"Erskine","year":"2017","journal-title":"PLoS One."},{"issue":"23","key":"10.1016\/j.ard.2026.06.027_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027451","article-title":"Herpes zoster and long-term cardiovascular risk","volume":"11","author":"Curhan","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.ard.2026.06.027_bib0022","article-title":"COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: a novel treatment strategy","volume":"9","author":"Khaledi","year":"2022","journal-title":"Front Med (Lausanne)."},{"issue":"21","key":"10.1016\/j.ard.2026.06.027_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.042670","article-title":"Viral infections and risk of cardiovascular disease: systematic review and meta-analysis","volume":"14","author":"Kawai","year":"2025","journal-title":"J Am Heart Assoc."},{"issue":"30","key":"10.1016\/j.ard.2026.06.027_bib0024","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1093\/eurheartj\/ehaf230","article-title":"Live zoster vaccination and cardiovascular outcomes: nationwide study","volume":"46","author":"Lee","year":"2025","journal-title":"Eur Heart J."},{"issue":"2","key":"10.1016\/j.ard.2026.06.027_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090428","article-title":"Herpes zoster vaccination and cardiovascular risk in diabetes","volume":"15","author":"Kornelius","year":"2025","journal-title":"BMJ Open."},{"key":"10.1016\/j.ard.2026.06.027_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1176920","article-title":"Effects of zoster vaccination and antivirals on stroke risk: systematic review","volume":"14","author":"Jia","year":"2023","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.ard.2026.06.027_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.55563\/clinexprheumatol\/cpu6r9","article-title":"Prevention and management of herpes zoster in arthritis","volume":"40","author":"Winthrop","year":"2022","journal-title":"Clin Exp Rheumatol."},{"issue":"Suppl 1","key":"10.1016\/j.ard.2026.06.027_bib0028","article-title":"Herpes zoster vaccine effectiveness against cardiovascular events - a systematic literature review and meta-analysis","volume":"46","author":"Williams","year":"2025","journal-title":"Eur Heart J."},{"issue":"4","key":"10.1016\/j.ard.2026.06.027_bib0029","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/13872877251351593","article-title":"The association between herpes zoster vaccination and the decreased risk of dementia: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Yin","year":"2025","journal-title":"J Alzheimers Dis."},{"issue":"Suppl 13","key":"10.1016\/j.ard.2026.06.027_bib0030","doi-asserted-by":"crossref","first-page":"A221","DOI":"10.1016\/j.jacc.2026.02.547","article-title":"26-A-18912-ACC herpes zoster vaccination and risk of cardiovascular events in patients with atherosclerotic cardiovascular disease","volume":"87","author":"Nguyen","year":"2026","journal-title":"JACC."},{"issue":"3","key":"10.1016\/j.ard.2026.06.027_bib0031","article-title":"Immunogenicity of recombinant zoster vaccine in RA patients on upadacitinib","volume":"11","author":"Winthrop","year":"2025","journal-title":"RMD Open."},{"issue":"1","key":"10.1016\/j.ard.2026.06.027_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-025-03565-0","article-title":"Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster","volume":"27","author":"Curtis","year":"2025","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.ard.2026.06.027_bib0033","article-title":"Recombinant zoster vaccine reduces all-cause mortality, but not major adverse cardiovascular events, in patients with immune-mediated inflammatory diseases receiving janus kinase inhibitors: a large-scale real-world retrospective cohort study","volume":"97","author":"Shih","year":"2025","journal-title":"J Med Virol [Internet]."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:09:53Z","timestamp":1791086993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726004127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0003496726004127"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.06.027","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella-zoster virus reactivation and cardiovascular risk: implications for patients receiving JAK inhibitors","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}